Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.67 USD | -2.72% | -3.66% | +56.46% |
May. 15 | Spyre Therapeutics, Inc. Announces Board Changes | CI |
May. 13 | Wells Fargo Adjusts Price Target on Spyre Therapeutics to $40 From $35, Maintains Overweight Rating | MT |
- Stock Market
- Equities
- SYRE Stock
- News Spyre Therapeutics, Inc.
- Analyst Reco.